These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22451356)

  • 1. Micro total bioassay system for oral drugs: evaluation of gastrointestinal degradation, intestinal absorption, hepatic metabolism, and bioactivity.
    Imura Y; Yoshimura E; Sato K
    Anal Sci; 2012; 28(3):197-9. PubMed ID: 22451356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro total bioassay system for ingested substances: assessment of intestinal absorption, hepatic metabolism, and bioactivity.
    Imura Y; Sato K; Yoshimura E
    Anal Chem; 2010 Dec; 82(24):9983-8. PubMed ID: 21090751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Openable Artificial Intestinal Tract System Enables the Evaluation of Drug Absorption in Caco-2 Cells through the Reduction in Thickness of the Unstirred Water Layer.
    Kono Y; Konishi S; Fujita T
    Biol Pharm Bull; 2019; 42(5):840-844. PubMed ID: 31061329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
    Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
    Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction.
    Letendre L; Scott M; Dobson G; Hidalgo I; Aungst B
    Pharm Res; 2004 Aug; 21(8):1457-62. PubMed ID: 15359582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digestion and absorption of phenolic compounds assessed by in vitro simulation methods. A review.
    Tarko T; Duda-Chodak A; Zajac N
    Rocz Panstw Zakl Hig; 2013; 64(2):79-84. PubMed ID: 23987074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyarginine Nanocapsules as a Potential Oral Peptide Delivery Carrier.
    Lollo G; Gonzalez-Paredes A; Garcia-Fuentes M; Calvo P; Torres D; Alonso MJ
    J Pharm Sci; 2017 Feb; 106(2):611-618. PubMed ID: 27855960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microfluidic device with 3-d hydrogel villi scaffold to simulate intestinal absorption.
    Kim SH; Lee JW; Choi I; Kim YC; Lee JB; Sung JH
    J Nanosci Nanotechnol; 2013 Nov; 13(11):7220-8. PubMed ID: 24245233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal transit and drug absorption.
    Kimura T; Higaki K
    Biol Pharm Bull; 2002 Feb; 25(2):149-64. PubMed ID: 11853157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug dissolution: significance of physicochemical properties and physiological conditions.
    Jambhekar SS; Breen PJ
    Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.
    Singh BN; Malhotra BK
    Clin Pharmacokinet; 2004; 43(15):1127-56. PubMed ID: 15568891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
    Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS
    Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental models for predicting drug absorption and metabolism.
    Alqahtani S; Mohamed LA; Kaddoumi A
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1241-54. PubMed ID: 23687990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of orally administered a promising chemotherapeutic agent flavopiridol in the intestine.
    Xia B; Liu X; Zhou Q; Feng Q; Li Y; Liu W; Liu Z
    Drug Dev Ind Pharm; 2013 Jun; 39(6):845-53. PubMed ID: 22563974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic Gastrointestinal Tract Functions for Metal Absorption Assessment in Edible Plants: Comparison to In Vivo Absorption.
    Lin L; Zheng F; Zhou H; Li S
    J Agric Food Chem; 2017 Aug; 65(30):6282-6287. PubMed ID: 28685577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfabrication technologies for oral drug delivery.
    Sant S; Tao SL; Fisher OZ; Xu Q; Peppas NA; Khademhosseini A
    Adv Drug Deliv Rev; 2012 May; 64(6):496-507. PubMed ID: 22166590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular evaluation of oral chemotherapy carriers.
    Blanchette J; Peppas NA
    J Biomed Mater Res A; 2005 Mar; 72(4):381-8. PubMed ID: 15666363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
    Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
    Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model.
    Kimura T; Iwasaki N; Yokoe JI; Haruta S; Yokoo Y; Ogawara KI; Higaki K
    Drug Metab Dispos; 2000 May; 28(5):577-81. PubMed ID: 10772638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.